Lanzamiento Enero 2027

Ensayo controlado aleatorizado2021Alimentación controladaFinanciación no declarada

Post-prandial effects of high-polyphenolic extra virgin olive oil on endothelial function in adults at risk for type 2 diabetes: A randomized controlled crossover trial

Njike VY, Ayettey R, Treu JA, Doughty KN, Katz DL

International journal of cardiology · 26 citas

Etiquetas de revisión

Alimentación controladaFinanciación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2021-02-04 · Int J Cardiol · vol. 330 · págs. 171–176
Editorial
Elsevier BV
Citado
34 citas · más que el 88% de estudios similares · 2.2× el promedio de su campo
Referencias
38 trabajos
Acceso
De pago
Áreas de investigación
Edible Oils Quality and Analysis · Phytochemicals and Antioxidant Activities · Fatty Acid Research and Health
Palabras clave
extra virgin olive oil, polyphenols, refined olive oil, endothelial function, flow-mediated dilation, type 2 diabetes risk, prediabetes, metabolic syndrome, postprandial effects, blood pressure, cardiovascular risk
MeSH
humans, diabetes mellitus, type 2, cross-over studies, postprandial period, adult, middle aged, female, male, olive oil, metabolic syndrome

5 autores

  • Valentine Yanchou Njike🇺🇸 · autor de correspondenciaYale University; Griffin Hospital; Yale Griffin Prevention Research Center
  • Rockiy G. Ayettey🇺🇸 · autor de correspondenciaYale University; Griffin Hospital; Yale Griffin Prevention Research Center
  • Judith A. Treu🇺🇸Yale University; Griffin Hospital; Yale Griffin Prevention Research Center
  • Kimberly N. Doughty🇺🇸Yale University; Griffin Hospital; Yale Griffin Prevention Research Center
  • David L. Katz🇺🇸Yale University; Yale Griffin Prevention Research Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Effects of olive oil on cardiovascular risk have been controversial. We compared the effects of high-polyphenolic extra virgin olive oil (EVOO) and refined olive oil without polyphenols on endothelial function (EF) in adults at risk for Type 2 diabetes mellitus (T2DM).

Methods

Randomized, controlled, double-blind, crossover trial of 20 adults (mean age 56.1 years; 10 women, 10 men) at risk for T2DM (i.e., as defined by either prediabetes or metabolic syndrome) assigned to one of two possible sequence permutations of two different single dose treatments (50 mL of high-polyphenolic EVOO or 50 mL of refined olive oil without polyphenols), with 1-week washout. Participants received their olive oils in a smoothie consisting of ½ cup frozen blueberries and 1 cup (8 oz) low-fat vanilla yogurt blended together. Primary outcome measure was EF measured as flow-mediated dilatation. Participants were evaluated before and 2 h after ingestion of their assigned olive oil treatment.

Results

EVOO acutely improved EF as compared to refined olive oil (1.2 ± 6.5% versus -3.6 ± 3.8%; p = 0.0086). No significant effects on systolic or diastolic blood pressure were observed.

Conclusions

High-polyphenolic EVOO acutely enhanced EF in the study cohort, whereas refined olive oil did not. Blood pressure effects were not observed. Reports on the vascular effects of olive oil ingestion should specify the characteristics of the oil.

Clinical trial registration number

NCT04025281.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.